Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
717.90
+5.13 (0.72%)
May 12, 2026, 11:52 AM EDT - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Net Product Sales Revenue
6.43B6.31B7.63B
Net Product Sales Revenue Growth
1.88%-17.30%7.79%
Total Collaboration Revenue
7.70B7.33B6.06B
Total Collaboration Revenue Growth
5.03%21.02%10.08%
Other Product Revenue
791.90M702.60M515.00M
Other Product Revenue Growth
12.71%36.43%-3.94%
Revenue (Total)
14.92B14.34B14.20B
Revenue (Total) Growth
4.02%0.99%8.27%
Updated Apr 29, 2026. Data Source: Fiscal.ai.